These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16680069)

  • 1. Bradykinin does not contribute to peripheral vascular tone in patients with cirrhosis and ascites.
    Helmy A; Ferguson JW; Hayes PC; Newby DE; Webb DJ
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):556-60. PubMed ID: 16680069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans.
    Witherow FN; Dawson P; Ludlam CA; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1667-70. PubMed ID: 12869356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites.
    Ferguson JW; Dover AR; Chia S; Cruden NL; Hayes PC; Newby DE
    Gut; 2006 Apr; 55(4):542-6. PubMed ID: 16299035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible nitric oxide synthase activity does not contribute to the maintenance of peripheral vascular tone in patients with heart failure.
    Dover AR; Chia S; Ferguson JW; Cruden NL; Megson IL; Fox KA; Newby DE
    Clin Sci (Lond); 2006 Oct; 111(4):275-80. PubMed ID: 16803456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Witherow FN; Helmy A; Webb DJ; Fox KA; Newby DE
    Circulation; 2001 Oct; 104(18):2177-81. PubMed ID: 11684627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of varying sodium intake on blood volume, forearm blood flow and vascular responsiveness to sympathetic stimulation in pre-ascitic cirrhosis.
    Wong F; Logan A; Blendis L
    Clin Invest Med; 1996 Jun; 19(3):184-94. PubMed ID: 8724822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the endothelium on vasoactive agents in patients with liver cirrhosis.
    Battaglia S; Angus P; Chin-Dusting JP
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1189-93. PubMed ID: 16824074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.
    Wotherspoon F; Browne DL; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Diabet Med; 2005 Jun; 22(6):697-702. PubMed ID: 15910619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular smooth muscle cell dysfunction in patients with migraine.
    Napoli R; Guardasole V; Zarra E; Matarazzo M; D'Anna C; Saccà F; Affuso F; Cittadini A; Carrieri PB; Saccà L
    Neurology; 2009 Jun; 72(24):2111-4. PubMed ID: 19528518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Block of inward rectifying K+ channels (KIR) inhibits bradykinin-induced vasodilatation in human forearm resistance vasculature.
    Dwivedi R; Saha S; Chowienczyk PJ; Ritter JM
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):e7-9. PubMed ID: 15591222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis.
    Mills NL; Törnqvist H; Robinson SD; Gonzalez M; Darnley K; MacNee W; Boon NA; Donaldson K; Blomberg A; Sandstrom T; Newby DE
    Circulation; 2005 Dec; 112(25):3930-6. PubMed ID: 16365212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of glucocorticoids on endothelial fibrinolytic and vasodilator function in humans.
    Dover AR; Hadoke PW; Walker BR; Newby DE
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):321-6. PubMed ID: 17878762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular B1 kinin receptors in patients with congestive heart failure.
    Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plethysmographic and in vitro studies of the vasodilator effect of furosemide (Lasix)].
    Biamino G; Wessel HJ; Nöring J; Schröder R
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):356-68. PubMed ID: 1176241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients.
    Taddei S; Versari D; Cipriano A; Ghiadoni L; Galetta F; Franzoni F; Magagna A; Virdis A; Salvetti A
    J Am Coll Cardiol; 2006 Aug; 48(3):508-15. PubMed ID: 16875977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasomotor effects of noradrenaline, acetylcholine, histamine, 5-hydroxytryptamine and bradykinin on snake (Trimeresurus flavoviridis) basilar arteries.
    Yoshinaga N; Okuno T; Watanabe Y; Matsumoto T; Shiraishi M; Obi T; Yabuki A; Miyamoto A
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Nov; 146(4):478-83. PubMed ID: 17604230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urotensin II evokes potent vasoconstriction in humans in vivo.
    Böhm F; Pernow J
    Br J Pharmacol; 2002 Jan; 135(1):25-7. PubMed ID: 11786476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.